TY - JOUR
T1 - Transcription factor engineering in CHO cells for recombinant protein production
AU - Gutiérrez-González, Matías
AU - Latorre, Yesenia
AU - Zúñiga, Roberto
AU - Aguillón, Juan Carlos
AU - Molina, María Carmen
AU - Altamirano, Claudia
N1 - Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/7/4
Y1 - 2019/7/4
N2 - The continuous increase of approved biopharmaceutical products drives the development of more efficient recombinant protein expression systems. Chinese hamster ovary (CHO) cells are the mainstay for this purpose but have some drawbacks, such as low levels of expression. Several strategies have been applied to increase the productivity of CHO cells with different outcomes. Transcription factor (TF) engineering has emerged as an interesting and successful approach, as these proteins can act as master regulators; the expression and function of a TF can be controlled by small molecules, and it is possible to design tailored TFs and promoters with desired features. To date, the majority of studies have focused on the use of TFs with growth, metabolic, cell cycle or endoplasmic reticulum functions, although there is a trend to develop new, synthetic TFs. Moreover, new synthetic biological approaches are showing promising advances for the development of specific TFs, even with tailored ligand sensitivity. In this article, we summarize the strategies to increase recombinant protein expression by modulating and designing TFs and with advancements in synthetic biology. We also illustrate how this class of proteins can be used to develop more robust expression systems.
AB - The continuous increase of approved biopharmaceutical products drives the development of more efficient recombinant protein expression systems. Chinese hamster ovary (CHO) cells are the mainstay for this purpose but have some drawbacks, such as low levels of expression. Several strategies have been applied to increase the productivity of CHO cells with different outcomes. Transcription factor (TF) engineering has emerged as an interesting and successful approach, as these proteins can act as master regulators; the expression and function of a TF can be controlled by small molecules, and it is possible to design tailored TFs and promoters with desired features. To date, the majority of studies have focused on the use of TFs with growth, metabolic, cell cycle or endoplasmic reticulum functions, although there is a trend to develop new, synthetic TFs. Moreover, new synthetic biological approaches are showing promising advances for the development of specific TFs, even with tailored ligand sensitivity. In this article, we summarize the strategies to increase recombinant protein expression by modulating and designing TFs and with advancements in synthetic biology. We also illustrate how this class of proteins can be used to develop more robust expression systems.
KW - Chinese hamster ovary cells
KW - biopharmaceuticals
KW - recombinant proteins
KW - transcription factor
UR - http://www.scopus.com/inward/record.url?scp=85065205051&partnerID=8YFLogxK
U2 - 10.1080/07388551.2019.1605496
DO - 10.1080/07388551.2019.1605496
M3 - Review article
C2 - 31030575
AN - SCOPUS:85065205051
SN - 0738-8551
VL - 39
SP - 665
EP - 679
JO - Critical Reviews in Biotechnology
JF - Critical Reviews in Biotechnology
IS - 5
ER -